Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome.

[1]  F. Wolfe,et al.  Pain, functional disability, and psychological status: a 12-month study of severity in fibromyalgia. , 1988, The Journal of rheumatology.

[2]  H. Moldofsky,et al.  Growth hormone and cortisol secretion in relation to sleep and wakefulness. , 1991, Journal of psychiatry & neuroscience : JPN.

[3]  P. Disdier,et al.  Severe fibromyalgia after hypophysectomy for Cushing's disease. , 1991, Arthritis and rheumatism.

[4]  J. Krueger,et al.  Interleukin-1 is involved in responses to sleep deprivation in the rabbit , 1994, Brain Research.

[5]  A. Komaroff,et al.  NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. , 1992, Annals of internal medicine.

[6]  L. Terenius,et al.  Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis , 1988, Pain.

[7]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[8]  X. Caro.  Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. , 1984, Arthritis and rheumatism.

[9]  D. Goldenberg.  Fibromyalgia and its relation to chronic fatigue syndrome, viral illness and immune abnormalities. , 1989, The Journal of rheumatology. Supplement.

[10]  E. D. de Kloet,et al.  Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. , 1993, The Journal of rheumatology.

[11]  M. Gately,et al.  Regulation of human cytolytic lymphocyte responses by interleukin-12. , 1992, Cellular immunology.

[12]  D. Rubinow,et al.  The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. , 1987, Annals of internal medicine.

[13]  A. Husband,et al.  Central nervous system influences on lymphocyte migration , 1992, Brain, Behavior, and Immunity.

[14]  R. Bennett.  Beyond fibromyalgia: ideas on etiology and treatment. , 1989, The Journal of rheumatology. Supplement.

[15]  A P Hollander,et al.  Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? , 1992, Scandinavian journal of rheumatology.

[16]  R. Pownall.  Biological rhythms in cell-mediated immunity: their relevance in rheumatology. , 1984, British journal of clinical practice. Supplement.

[17]  B. Freundlich,et al.  Fibromyalgia and parvovirus infection. , 1991, Arthritis and rheumatism.

[18]  R. Sapolsky,et al.  Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. , 1987, Science.

[19]  R. Fielding,et al.  Increased interleukin 1β in human skeletal muscle after exercise , 1989 .

[20]  M. Moal,et al.  Natural killer cell activity is associated with brain asymmetry in male mice , 1991, Brain, Behavior, and Immunity.

[21]  C. Kilts,et al.  Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin- releasing factor , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[22]  G. Trinchieri,et al.  Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity , 1985, The Journal of experimental medicine.

[23]  G. Scholz,et al.  The alpha sleep pattern quantitative analysis and functional aspects , 1988 .

[24]  M. Sharpe,et al.  Mania and Recovery from Chronic Fatigue Syndrome , 1991, Journal of the Royal Society of Medicine.

[25]  M. Chard,et al.  Chronic coxsackie B infection mimicking primary fibromyalgia. , 1989, The Journal of rheumatology.

[26]  M. Yunus,et al.  Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. , 1985, Arthritis and rheumatism.

[27]  J. Parker,et al.  Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. , 2010 .

[28]  S. Savastano,et al.  Interleukin-1 beta and beta-endorphin circadian rhythms are inversely related in normal and stress-altered sleep. , 1992, The International journal of neuroscience.

[29]  K. P. May,et al.  Sleep apnea in male patients with the fibromyalgia syndrome. , 1993, The American journal of medicine.

[30]  H. Merskey,et al.  Progress in Fibromyalgia and Myofascial Pain , 1993 .

[31]  H. Moldofsky,et al.  Two contributions to understanding of the "fibrositis" syndrome. , 1977, Bulletin on the rheumatic diseases.

[32]  J. Krueger,et al.  Bacterial products, cytokines and sleep. , 1989, The Journal of rheumatology. Supplement.

[33]  J. Blalock,et al.  Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. , 1987, Journal of immunology.

[34]  J. Krueger,et al.  Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. , 1989, The American journal of physiology.

[35]  J. Rodin,et al.  Modulation of human natural killer cell activity by exposure to uncontrollable stress , 1992, Brain, Behavior, and Immunity.

[36]  J. Blalock.  A molecular basis for bidirectional communication between the immune and neuroendocrine systems. , 1989, Physiological reviews.

[37]  J. Neubauer,et al.  Sleep, sleep apnea and the fibromyalgia syndrome. , 1986, The Journal of rheumatology.

[38]  T. Patterson,et al.  Reduction of immune function in life stress and depression , 1990, Biological Psychiatry.

[39]  D. Bell,et al.  Interleukin-2 and the chronic fatigue syndrome. , 1989, Annals of Internal Medicine.

[40]  J. Yodoi,et al.  The expression of IL-2R alpha-chain is enhanced by activation of adenylate cyclase in large granular lymphocytes and natural killer cells. , 1991, Journal of Immunology.

[41]  H. Moldofsky,et al.  Sleep and musculoskeletal pain. , 1986, The American journal of medicine.

[42]  C. Dinarello.  Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[43]  Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates. , 1989, Natural immunity and cell growth regulation.

[44]  G. Nisticó,et al.  Is interleukin 2 a neuromodulator in the brain? , 1991, Trends in Neurosciences.

[45]  S. Schwartz,et al.  Natural killer cell activity in depressive illness: preliminary report , 1989, Biological Psychiatry.

[46]  P. Procacci.  Methods for the study of pain threshold in man , 1979 .

[47]  R. Bennett,et al.  Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. , 1983, Arthritis and rheumatism.

[48]  W. Banks,et al.  The interleukins-1α, -1β, and -2 do not acutely disrupt the murine blood - brain barrier , 1992 .

[49]  L. Aarden,et al.  IL-6 is an intermediate in IL-1-induced thymocyte proliferation. , 1989, Journal of immunology.

[50]  E. Sternberg.  Hyperimmune fatigue syndromes: diseases of the stress response? , 1993, The Journal of rheumatology.

[51]  P. Cowen,et al.  Abnormalities of sleep in patients with the chronic fatigue syndrome. , 1993, BMJ.

[52]  P. Roberts-Thomson,et al.  Diurnal variation of lymphocyte subsets identified by monoclonal antibodies. , 1983, British medical journal.

[53]  C. Grossman.  Interactions between the gonadal steroids and the immune system. , 1985, Science.

[54]  A. Fauci,et al.  The effects of interleukin 1 on human B cell activation and proliferation. , 1983, Journal of immunology.

[55]  C. Dinarello,et al.  Increased plasma interleukin-1 activity in women after ovulation. , 1985, Science.

[56]  D. Dinges,et al.  Catastrophes, sleep, and public policy: consensus report. , 1988, Sleep.

[57]  A. Reinberg,et al.  Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects. , 1988, The Journal of clinical investigation.

[58]  W. Mendelson,et al.  Sleep disturbance in chronic fatigue syndrome. , 1993, Journal of psychosomatic research.

[59]  D. Felson,et al.  A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. , 1986, The Journal of rheumatology.

[60]  R. Bond,et al.  Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. , 1989, Archives of general psychiatry.

[61]  A. Hartz,et al.  Factors associated with severity of symptoms in patients with chronic unexplained muscular aching. , 1989, Annals of the rheumatic diseases.

[62]  McCain Ga,et al.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. , 1989 .

[63]  F. Wolfe.  The Epidemilogy of Fibromyalgia , 1993 .

[64]  F. Salaffi,et al.  Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain) , 1990, The Journal of rheumatology.

[65]  B. Rigas,et al.  Human salivary eicosanoids: circadian variation. , 1983, Biochemical and biophysical research communications.

[66]  C. Janeway,et al.  Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. , 1984, Journal of immunology.

[67]  R. Philip,et al.  Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 , 1986, Nature.

[68]  W. Vainchenker,et al.  Regulation of the expression of IL-6 in human monocytes. , 1989, Journal of immunology.

[69]  D. Wallace,et al.  Fibromyalgia and interleukin-2 therapy for malignancy. , 1988, Annals of internal medicine.

[70]  E. Haus,et al.  Chronobiology in hematology and immunology. , 1983, The American journal of anatomy.

[71]  G. Mitchell.  Cellular interactions in the immune response: (The 2nd International Convocation on Immunology, Buffalo, N.Y. 1970)—Edited by S. Cohen, G. Cudkowicz and R. T. McCluskey. S. Karger, Basel, 1971. 310 pp. £10.92. , 1972 .

[72]  H. Moldofsky,et al.  Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. , 1992, The Journal of rheumatology.

[73]  E. Goetzl,et al.  Neuroimmune Networks: Physiology and Diseases , 1989 .

[74]  K. Biemann,et al.  Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination. , 1984, The Journal of biological chemistry.

[75]  H. Moldofsky,et al.  Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation , 1976, Psychosomatic medicine.

[76]  M. Yunus,et al.  Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. , 1992, The Journal of rheumatology.

[77]  H. Moldofsky.  A Chronobiologic Theory of Fibromyalgia , 1993 .

[78]  H. Moldofsky,et al.  The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan. , 1980, Electroencephalography and clinical neurophysiology.

[79]  H. Moldofsky,et al.  Sleep and symptoms in fibrositis syndrome after a febrile illness. , 1988, The Journal of rheumatology.

[80]  James F. Jones,et al.  Chronic fatigue syndrome: a working case definition. , 1988, Annals of internal medicine.

[81]  C. Dinarello,et al.  Interleukin-1 receptor type I mRNA in mouse brain as affected by peripheral administration of bacterial lipopolysaccharide , 1994, Neuroscience Letters.

[82]  D. Gladman,et al.  Fibromyalgia in human immunodeficiency virus infection. , 1990, The Journal of rheumatology.

[83]  J. Kiecolt-Glaser,et al.  Psychosocial Modifiers of Immunocompetence in Medical Students , 1984, Psychosomatic medicine.

[84]  P. Lavie.  Modelling sleep propensity—a need for rethinking , 1992, Journal of sleep research.

[85]  R. Herberman,et al.  Natural killer cells. , 1986, Annual review of medicine.

[86]  H. Moldofsky,et al.  Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”) , 1978, Pain.

[87]  H. Moldofsky,et al.  Musculosketal Symptoms and Non‐REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects , 1975, Psychosomatic medicine.

[88]  F. Wolfe,et al.  Fibrositis: symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals. , 1985, The Journal of rheumatology.

[89]  D. Buchwald,et al.  Sleep disorders in patients with chronic fatigue. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[90]  J. Krueger,et al.  A neuronal group theory of sleep function , 1993, Journal of sleep research.

[91]  Josef K. Wang.  Advances in Pain Research and Therapy , 1980 .

[92]  F. Dammacco,et al.  Analogues in immunology , 1984, La Ricerca in clinica e in laboratorio.

[93]  R. Schmidt,et al.  Characteristics and uses of natural killer cells. , 1988, Immunology today.

[94]  D. Goldenberg.  Do infections trigger fibromyalgia? , 1993, Arthritis and rheumatism.

[95]  Paul H. Black,et al.  Immunosuppression in mice induced by cold water stress , 1990, Brain, Behavior, and Immunity.

[96]  P. Manu,et al.  Alpha-Delta Sleep in Patients With a Chief Complaint of Chronic Fatigue , 1994, Southern medical journal.

[97]  Z. Kronfol,et al.  Natural killer cell activity in adolescents with major depression , 1991, Biological Psychiatry.

[98]  A. Steere,et al.  Lyme Disease Associated with Fibromyalgia , 1992, Annals of Internal Medicine.

[99]  V. Hsu,et al.  "Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia. , 1993, Arthritis and rheumatism.

[100]  J. Krueger.  Somnogenic activity of immune response modifiers. , 1990, Trends in pharmacological sciences.

[101]  G. Littlejohn,et al.  Diurnal variation in the symptoms and signs of the fibromyalgia syndrome [FS] , 1993 .

[102]  F. Wolfe.  Fibromyalgia:: On Diagnosis and Certainty , 1993 .

[103]  H. Moldofsky,et al.  Sleep and cerebrospinal fluid interleukin-1-like activity in the cat. , 1988, The International journal of neuroscience.

[104]  J. Branco,et al.  Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. , 1994, The Journal of rheumatology.

[105]  M. Mantovani,et al.  Circadian rhythm of natural killer cell activity in vitiligo. , 1989, Journal of the American Academy of Dermatology.

[106]  E. Shorter.  Chronic fatigue in historical perspective. , 1993, Ciba Foundation symposium.

[107]  J. Alegre,et al.  Lack of association between fibromyalgia and sleep apnoea syndrome. , 1992, Annals of the rheumatic diseases.

[108]  Craig W. Reynolds,et al.  Differential regulation of interleukin-1 gene expression in human CD3- large granular lymphocytes. , 1990, Cellular immunology.

[109]  E. Griep,et al.  Evidence for Neuroendoncrine Disturbance Following Physical Exercise in Primary Fibromyalgia Syndrome , 1993 .

[110]  H. Moldofsky.  Immune-neuroendocrine-thermal mechanisms and the sleep-wake system. , 1994 .

[111]  W. Urba,et al.  The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  J. Horne,et al.  Alpha-like EEG activity in non-REM sleep and the fibromyalgia (fibrositis) syndrome. , 1991, Electroencephalography and clinical neurophysiology.

[113]  M. Yunus,et al.  Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. , 1993, The Journal of rheumatology.

[114]  B. Danneskiold-Samsøe,et al.  Inter-relations between clinical parameters and muscle function in patients with primary fibromyalgia. , 1989, Clinical and experimental rheumatology.

[115]  V. Wright,et al.  Comparison of sleep in osteoarthritic patients and age and sex matched healthy controls. , 1988, Annals of the rheumatic diseases.

[116]  I. Pilowsky,et al.  Sleep disturbance in pain clinic patients , 1985, Pain.

[117]  R. Bennett.  The Origin of Myopain:: An Integrated Hypothesis of Focal Muscle Changes and Sleep Disturbance in Patients with the Fibromyalgia Syndrome , 1993 .

[118]  H. Solvason,et al.  Regulation of Natural Immunity (NK Activity) by Conditioning a , 1987, Annals of the New York Academy of Sciences.

[119]  M. Demitrack,et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[120]  I. Hickie,et al.  Cell‐mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression , 1992, Clinical and experimental immunology.

[121]  H. Moldofsky.  Nonrestorative sleep and symptoms after a febrile illness in patients with fibrositis and chronic fatigue syndromes. , 1989, The Journal of rheumatology. Supplement.

[122]  W. Heneine,et al.  Assessment of a Retrovirus Sequence and Other Possible Risk Factors for the Chronic Fatigue Syndrome in Adults , 1993, Annals of Internal Medicine.

[123]  H. Moldofsky,et al.  Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome. , 1991, Canadian journal of psychology.

[124]  A. Komaroff,et al.  Review of laboratory findings for patients with chronic fatigue syndrome. , 1991, Reviews of infectious diseases.

[125]  J. Levy,et al.  Chronic fatigue syndrome: clinical condition associated with immune activation , 1991, The Lancet.

[126]  H. Moldofsky.  Fibromyalgia, sleep disorder and chronic fatigue syndrome. , 2007, Ciba Foundation symposium.

[127]  M. Sharpe,et al.  A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.

[128]  H. Moldofsky,et al.  Litigation, sleep, symptoms and disabilities in postaccident pain (fibromyalgia) , 1993, The Journal of rheumatology.

[129]  F. Herrmann,et al.  Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor. , 1988, The Journal of clinical investigation.

[130]  I. Tobler,et al.  Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat. , 1984, European journal of pharmacology.

[131]  M. Yunus,et al.  Relationship of clinical features with psychological status in primary fibromyalgia. , 1991, Arthritis and rheumatism.

[132]  A. Santoni,et al.  Reduced natural killer cell activity in major depression: neuroendocrine implications , 1989, Psychoneuroendocrinology.

[133]  R. Bennett,et al.  Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. , 1992, Arthritis and rheumatism.

[134]  A. Dunn,et al.  Psychoneuroimmunology for the psychoneuroendocrinologist: A review of animal studies of nervous system-immune system interactions , 1989, Psychoneuroendocrinology.

[135]  G. Snyder,et al.  Cachectin alters anterior pituitary hormone release by a direct action in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[136]  P. Allavena,et al.  Human large granular lymphocytes are potent producers of interleukin-1 , 1984, Nature.

[137]  G. Neeck,et al.  Thyroid function in patients with fibromyalgia syndrome. , 1992, The Journal of rheumatology.

[138]  J. H. Daruna,et al.  Psychosocial effects on immune function: neuroendocrine pathways. , 1990, Psychosomatics.

[139]  C. Bowden,et al.  Natural killer cell activity in major depression. , 1987, The American journal of psychiatry.

[140]  M. Tsang,et al.  Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. , 1991, Cytokine.

[141]  I. Russell,et al.  Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[142]  A Lecture on Lumbago: Its Lessons and Analogues , 1904, British medical journal.

[143]  I. Frank,et al.  Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients , 1992, The Journal of experimental medicine.

[144]  H. Moldofsky,et al.  The relationship of interleukin‐1 and immune functions to sleep in humans. , 1986, Psychosomatic medicine.

[145]  P. Jennum,et al.  Sleep and other symptoms in primary fibromyalgia and in healthy controls. , 1993, The Journal of rheumatology.

[146]  P. Lipsky,et al.  The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen. , 1983, Journal of immunology.

[147]  J. Weiss,et al.  Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[148]  D. Felson,et al.  The natural history of fibromyalgia. , 1986, Arthritis and rheumatism.

[149]  H. Moldofsky,et al.  Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome). , 1986, Psychosomatic medicine.

[150]  P. Bongrand,et al.  Are there circadian variations of polymorphonuclear phagocytosis in man? , 1988, Chronobiology international.

[151]  Romano Tj.  Fibromyalgia in children; diagnosis and treatment. , 1991 .

[152]  J. Krueger,et al.  Microinjection of interleukin-1 into brain: Separation of sleep and fever responses , 1989, Physiology & Behavior.

[153]  N. Lahat,et al.  Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome. , 1991, Arthritis and rheumatism.